252 related articles for article (PubMed ID: 21923443)
41. Search for predictors of nontherapeutic INR results with warfarin therapy.
McGriff-Lee NJ; Csako G; Chen JT; Dang DK; Rosenfeld KG; Cannon RO; Macklin LR; Wesley RA;
Ann Pharmacother; 2005 Dec; 39(12):1996-2002. PubMed ID: 16288081
[TBL] [Abstract][Full Text] [Related]
42. Increase in international normalized ratio after smoking cessation in a patient receiving warfarin.
Evans M; Lewis GM
Pharmacotherapy; 2005 Nov; 25(11):1656-9. PubMed ID: 16232028
[TBL] [Abstract][Full Text] [Related]
43. Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model.
Miki A; Ohtani H; Sawada Y
J Clin Pharm Ther; 2011 Dec; 36(6):642-50. PubMed ID: 21143257
[TBL] [Abstract][Full Text] [Related]
44. Cranberry and warfarin interaction: a case report and review of the literature.
Haber SL; Cauthon KA; Raney EC
Consult Pharm; 2012 Jan; 27(1):58-65. PubMed ID: 22231999
[TBL] [Abstract][Full Text] [Related]
45. Warfarin induced coagulopathy in children: assessment of a conservative approach.
Bauman ME; Black K; Bauman ML; Kuhle S; Bajzar L; Massicotte MP
Arch Dis Child; 2011 Feb; 96(2):164-7. PubMed ID: 21068076
[TBL] [Abstract][Full Text] [Related]
46. Warfarin and acetaminophen interaction.
Gebauer MG; Nyfort-Hansen K; Henschke PJ; Gallus AS
Pharmacotherapy; 2003 Jan; 23(1):109-12. PubMed ID: 12523469
[TBL] [Abstract][Full Text] [Related]
47. Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study.
Mahé I; Bertrand N; Drouet L; Bal Dit Sollier C; Simoneau G; Mazoyer E; Caulin C; Bergmann JF
Haematologica; 2006 Dec; 91(12):1621-7. PubMed ID: 17145598
[TBL] [Abstract][Full Text] [Related]
48. Effect of casopitant, a novel NK-1 receptor antagonist, on the pharmacokinetics and pharmacodynamics of steady-state warfarin.
Kirby LC; Johnson BM; Adams LM; Eberwein DJ; Zhang K; Murray SC; Lates CD; Blum RA; Morris SR
J Clin Pharmacol; 2010 May; 50(5):566-75. PubMed ID: 20220045
[TBL] [Abstract][Full Text] [Related]
49. Interaction between warfarin and nafcillin: case report and review of the literature.
Kim KY; Frey RJ; Epplen K; Foruhari F
Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
[TBL] [Abstract][Full Text] [Related]
50. Frequency of concurrent use of warfarin with potentially interacting drugs.
Wittkowsky AK; Boccuzzi SJ; Wogen J; Wygant G; Patel P; Hauch O
Pharmacotherapy; 2004 Dec; 24(12):1668-74. PubMed ID: 15585436
[TBL] [Abstract][Full Text] [Related]
51. Patient factors that influence warfarin dose response.
White PJ
J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
[TBL] [Abstract][Full Text] [Related]
52. [Hereditary warfarin resistance].
Lappegård KT
Tidsskr Nor Laegeforen; 2000 Nov; 120(27):3257-8. PubMed ID: 11187165
[TBL] [Abstract][Full Text] [Related]
53. Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin.
Bohm NM; Crosby B
Ann Pharmacother; 2012; 46(7-8):e19. PubMed ID: 22764328
[TBL] [Abstract][Full Text] [Related]
54. Enzymatic shunting: resolving the acetaminophen-warfarin controversy.
Lehmann DE
Pharmacotherapy; 2000 Dec; 20(12):1464-8. PubMed ID: 11130219
[TBL] [Abstract][Full Text] [Related]
55. Elevated international normalized ratio values associated with concomitant use of warfarin and ceftriaxone.
Clark TR; Burns S
Am J Health Syst Pharm; 2011 Sep; 68(17):1603-5. PubMed ID: 21856805
[TBL] [Abstract][Full Text] [Related]
56. An adverse interaction between warfarin and capecitabine: a case report and review of the literature.
Copur MS; Ledakis P; Bolton M; Morse AK; Werner T; Norvell M; Muhvic J; Chu E
Clin Colorectal Cancer; 2001 Nov; 1(3):182-4. PubMed ID: 12450435
[TBL] [Abstract][Full Text] [Related]
57. Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction.
Arnold LM; Nissen LR; Ng TM
Pharmacotherapy; 2005 Jun; 25(6):904-7. PubMed ID: 15927911
[TBL] [Abstract][Full Text] [Related]
58. Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy.
Kuo AM; Brown JN; Clinard V
J Clin Pharm Ther; 2012 Oct; 37(5):505-9. PubMed ID: 22449298
[TBL] [Abstract][Full Text] [Related]
59. Acetaminophen causes an increased International Normalized Ratio by reducing functional factor VII.
Whyte IM; Buckley NA; Reith DM; Goodhew I; Seldon M; Dawson AH
Ther Drug Monit; 2000 Dec; 22(6):742-8. PubMed ID: 11128244
[TBL] [Abstract][Full Text] [Related]
60. Potential interaction between telithromycin and warfarin.
Kolilekas L; Anagnostopoulos GK; Lampaditis I; Eleftheriadis I
Ann Pharmacother; 2004 Sep; 38(9):1424-7. PubMed ID: 15280511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
